This Guidance Note highlights the importance of the trading status for a life sciences company and sets out the technical analysis of what constitutes trade. The trading status of life sciences companies has been an area that HMRC look carefully at, particularly when assessing a company’s ability to access incentives such as the patent box . . .
This content is restricted to subscribers. To view this content please register an account.
If you are already a subscriber, please login below.